Learn More About the 2026 Summit
This July, join structural biologists, medicinal chemists, computational scientists and discovery leaders at the 3rd Structure-Based Drug Design Summit Boston to explore how leading organizations are leveraging experimental techniques and integrating structural biology and AI-driven modelling to accelerate early drug discovery and tackle increasingly complex targets.
Explore exclusive content and learn more about why you should connect with trailblazers from firms like AbbVie, AstraZeneca, Daiichi-Sankyo, Gilead, GSK, and many more.
Speaker Interview with Ilaria Ferlenghi
Take a look at our exclusive interview with expert speaker Ilaria Ferlenghi, Associate Director of Research & Senior Scientific Leader at GlaxoSmithKline Vaccines.
Explore the Agenda
Preview expert-led case studies on AI-enabled structure-based drug design, cryo-EM breakthroughs and complex target biology, alongside interactive discussions and hands-on workshops across three content-rich days.
Partner With Us
Position your organization as the go-to solution provider by showcasing your technologies, services and expertise to structural biology and drug discovery leaders shaping the next generation of discovery workflows.
Join Biopharma Experts
Connect with structural biologists, medicinal chemists, computational scientists and discovery leaders through collaborative discussions, roundtables and dedicated networking sessions to elevate structural insights and strengthen discovery decisions.